|
1
|
Chen JG, Chen WQ, Zhang SW, Zheng RS, Zhu
J and Zhang YH: Incidence and mortality of liver cancer in China:
An analysis on data from the National Registration System between
2003 and 2007. Zhonghua Liu Xing Bing Xue Za Zhi. 33:547–553.
2012.(In Chinese). PubMed/NCBI
|
|
2
|
Turk V, Kos J and Turk B: Cysteine
cathepsins (proteases) - on the main stage of cancer? Cancer Cell.
5:409–410. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Keppler D, Sameni M, Moin K, Mikkelsen T,
Diglio CA and Sloane BF: Tumor progression and angiogenesis:
cathepsin B & Co. Biochem Cell Biol. 74:799–810. 1996.
View Article : Google Scholar
|
|
4
|
Zhang H, Zhong C, Shi L, Guo Y and Fan Z:
Granulysin induces cathepsin B release from lysosomes of target
tumor cells to attack mitochondria through processing of bid
leading to Necroptosis. J Immunol. 182:6993–7000. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gocheva V and Joyce JA: Cysteine
cathepsins and the cutting edge of cancer invasion. Cell Cycle.
6:60–64. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohamed MM and Sloane BF: Cysteine
cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer.
6:764–775. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vasiljeva O, Reinheckel T, Peters C, Turk
D, Turk V and Turk B: Emerging roles of cysteine cathepsins in
disease and their potential as drug targets. Curr Pharm Des.
13:387–403. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jain M, Bakhshi S, Shukla AA and Chauhan
SS: Cathepsins B and L in peripheral blood mononuclear cells of
pediatric acute myeloid leukemia: potential poor prognostic
markers. Ann Hematol. 89:1223–1232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nouh MA, Mohamed MM, El-Shinawi M, Shaalan
MA, Cavallo-Medved D, Khaled HM and Sloane BF: Cathepsin B: a
potential prognostic marker for inflammatory breast cancer. J
Transl Med. 9:12011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tummalapalli P, Spomar D, Gondi CS,
Olivero WC, Gujrati M, Dinh DH and Rao JS: RNAi-mediated abrogation
of cathepsin B and MMP-9 gene expression in a malignant meningioma
cell line leads to decreased tumor growth, invasion and
angiogenesis. Int J Oncol. 31:1039–1050. 2007.PubMed/NCBI
|
|
11
|
Malla R, Gopinath S, Alapati K, Gondi CS,
Gujrati M, Dinh DH, Mohanam S and Rao JS: Downregulation of uPAR
and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax
and inhibition of the PI3K/Akt pathway in gliomas. PLoS One.
5:e137312010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Tan H, Dong X, et al: Antisense
integrin alphaV and beta3 gene therapy suppresses subcutaneously
implanted hepatocellular carcinomas. Dig Liver Dis. 39:557–565.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eden G, Archinti M, Furlan F, Murphy R and
Degryse B: The urokinase receptor interactome. Curr Pharm Des.
17:1874–1889. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Premzl A, Zavasnik-Bergant V, Turk V and
Kos J: Intracellular and extracellular cathepsin B facilitate
invasion of MCF-10A neoT cells through reconstituted extracellular
matrix in vitro. Exp Cell Res. 283:206–214. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Withana NP, Blum G, Sameni M, et al:
Cathepsin B inhibition limits bone metastasis in breast cancer.
Cancer Res. 72:1199–1209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu D, Wang H, Li Z, et al: Cathepsin B may
be a potential biomarker in cervical cancer. Histol Histopathol.
27:79–87. 2012.
|
|
17
|
Franke TF, Yang SI, Chan TO, Datta K,
Kazlauska A, Morrison DK, Kaplan DR and Tsichlis PN: The protein
kinase encoded by the Akt proto-oncogene is a target of the
PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:727–736.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bellacosa A, Kumar CC, Di Cristofano A and
Testa JR: Activation of AKT kinases in cancer: implications for
therapeutic targeting. Adv Cancer Res. 94:29–86. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Manning BD and Cantley LC: AKT/PKB
signaling: navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Victor BC, Anbalagan A, Mohamed MM, Sloane
BF and Cavallo-Medved D: Inhibition of cathepsin B activity
attenuates extracellular matrix degradation and inflammatory breast
cancer invasion. Breast Cancer Res. 13:R1152011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gupta R, Nalla AK, Gogineni VR, et al:
uPAR/cathepsin B overexpression reverse angiogenesis by rescuing
FAK phosphorylation in uPAR/cathepsin B down regulated meningioma.
PLoS One. 6:e171232011. View Article : Google Scholar : PubMed/NCBI
|
